Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers

Biosimilars present a necessary and timely opportunity for physicians, patients and healthcare systems. If suitably developed clinically, manufactured to the correct standards and used appropriately, they can positively impact on the financial sustainability of healthcare systems. A critical conside...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabernero, Josep, Vyas, Malvika, Giuliani, Rosa, Arnold, Dirk, Cardoso, Fatima, Casali, Paolo G, Cervantes, Andres, Eggermont, Alexander MM, Eniu, Alexandru, Jassem, Jacek, Pentheroudakis, George, Peters, Solange, Rauh, Stefan, Zielinski, Christoph C, Stahel, Rolf A, Voest, Emile, Douillard, Jean-Yves, McGregor, Keith, Ciardiello, Fortunato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: ESMO Open 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5419210/
https://www.ncbi.nlm.nih.gov/pubmed/28848668
http://dx.doi.org/10.1136/esmoopen-2016-000142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5419210/
https://www.ncbi.nlm.nih.gov/pubmed/28848668
http://dx.doi.org/10.1136/esmoopen-2016-000142

Ejemplares similares